Hearing Loss Trial, Recruiting NCT06776705 Sponsor: Chinese University of Hong Kong Condition: Hearing Loss
Back to Hearing Loss

Hearing Loss Trial, Recruiting

NCT06776705
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are Chinese, right-handed, and between 60 and 80 years old
  • You have had tinnitus (ringing or noise in the ears) for at least 3 months
  • You have sleep problems, shown by scoring above 5 on a standard sleep quality questionnaire called the PSQI
  • You are able to manage your daily activities on your own without significant difficulty

Who may not be able to join:

  • You have been found to have a problem with your ear canal or eardrum after an ear examination
  • You have previously been diagnosed with Meniere's disease or a type of non-cancerous ear tumour called an acoustic neuroma
  • You have a history of neurological conditions (such as stroke or epilepsy) or mental health disorders
  • You have physical health problems that would make it hard for you to attend treatment sessions regularly
  • You are already receiving regular treatments such as talking therapy (cognitive behavioural therapy) or music therapy
  • You are currently taking medication that affects your mood, mind, or hearing ability
  • You have significant difficulties with communication (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Hanna LU, PhD, Chinese University of Hong Kong

Phone: 852-28314305

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
15 January 2025
Est. completion
31 December 2025

Where this trial is recruiting

Hong Kong

Primary endpoints

Tinnitus Primary Functions Questionnaire (TPFQ); Pittsburg Sleep Quality Index (PSQI)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov